Steck A J, Früh J
Neurologische Universitätsklinik, Kantonsspital Basel.
Schweiz Med Wochenschr. 1995 Jun 17;125(24):1216-22.
We discuss current approaches in the treatment of immune mediated neuropathies and review recent progress in management. Intensive evaluation has led to improved diagnosis of the cause of neuropathies. Because immunosuppressive drugs are potentially hazardous, strict guidelines for their clinical use, including clinical immunological, neurophysiological and histological investigations, should be followed.
我们讨论了免疫介导性神经病的当前治疗方法，并回顾了管理方面的最新进展。深入评估已改善了对神经病病因的诊断。由于免疫抑制药物具有潜在危险性，因此应遵循其临床使用的严格指南，包括临床免疫学、神经生理学和组织学检查。
